Skip to main content
Signal8

Chan Mitchell

SEC insider (Form 3/4/5 filer). CIK 0001789335. Chief Financial Officer at REGENXBIO Inc. (RGNX) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in ROCKVILLE, MD.

Companies Chan Mitchell has filed insider reports for

  • REGENXBIO Inc. (RGNX): Officer, Chief Financial Officer
  • Avalo Therapeutics, Inc. (AVTX): Director
Chan Mitchell profile photo

Chan Mitchell

CIK: 0001789335

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

REGENXBIO Inc. logo
RGNX

REGENXBIO Inc.

Officer
Avalo Therapeutics, Inc. logo
AVTX

Avalo Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Sep 1, 2026
    Tax Payment
    Direct
    4.9K shares at avg. $9.32$46K
  • Avalo Therapeutics, Inc. logo
    AVTX

    Avalo Therapeutics, Inc.

    May 6, 2026
    Sale
    Direct
    3.2K shares at avg. $22.88$72K
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 6, 2026
    Award
    Direct
    73.7K shares-
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Sep 1, 2025
    Tax Payment
    Direct
    4.9K shares at avg. $8.93$44K
  • Avalo Therapeutics, Inc. logo
    AVTX

    Avalo Therapeutics, Inc.

    Jun 17, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    20.1K shares-
  • Avalo Therapeutics, Inc. logo
    AVTX

    Avalo Therapeutics, Inc.

    Mar 28, 2025
    Exercise
    Direct
    3.2K shares-
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 2, 2025
    Award

    Stock Options (Right to buy)

    Direct
    62.5K shares-
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Sep 16, 2024
    Award
    Direct
    58.9K shares-

1-8 of 8